X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13) 13
analysis (9) 9
humans (9) 9
oncology (9) 9
female (8) 8
hematology (8) 8
male (8) 8
adult (6) 6
cancer (6) 6
adolescent (5) 5
aged (5) 5
middle aged (5) 5
multiple myeloma (5) 5
treatment outcome (5) 5
bortezomib (4) 4
care and treatment (4) 4
chemotherapy (4) 4
clinical trials (4) 4
hematology, oncology and palliative medicine (4) 4
leukemia (4) 4
medicine & public health (4) 4
monoclonal antibodies (4) 4
patients (4) 4
therapy (4) 4
aged, 80 and over (3) 3
antineoplastic agents (3) 3
brazil (3) 3
busulfan (3) 3
child (3) 3
child, preschool (3) 3
children (3) 3
dexamethasone (3) 3
diethyldithiocarbamate (3) 3
disease-free survival (3) 3
health aspects (3) 3
hplc (3) 3
leukemia, myelogenous, chronic, bcr-abl positive - blood (3) 3
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (3) 3
motivation (3) 3
prognosis (3) 3
survival (3) 3
time factors (3) 3
young adult (3) 3
acute myeloid leukemia (2) 2
antibody daratumumab (2) 2
antimitotic agents (2) 2
antineoplastic agents - therapeutic use (2) 2
brazil - epidemiology (2) 2
cell survival (2) 2
chemistry, analytical (2) 2
chemistry, multidisciplinary (2) 2
chronic myeloid leukemia (2) 2
daratumumab (2) 2
diagnosis (2) 2
doxorubicin (2) 2
drug administration schedule (2) 2
drug therapy (2) 2
environmental sciences (2) 2
epidemiology (2) 2
expression (2) 2
follow-up studies (2) 2
genetic aspects (2) 2
growth (2) 2
hemic and lymphatic diseases (2) 2
imatinib mesylate - blood (2) 2
imatinib mesylate - therapeutic use (2) 2
infant (2) 2
infant, newborn (2) 2
lenalidomide (2) 2
management (2) 2
medicine, research & experimental (2) 2
nitrogen (2) 2
palliative care (2) 2
pharmacokinetics (2) 2
plus rituximab (2) 2
pomalidomide (2) 2
population pharmacokinetics (2) 2
protocol (2) 2
reproducibility of results (2) 2
safety (2) 2
surgery (2) 2
targeting cd38 (2) 2
transplantation (2) 2
transplants & implants (2) 2
trial (2) 2
1st-line treatment (1) 1
abnormal karyotype (1) 1
abridged index medicus (1) 1
absorption (1) 1
acid (1) 1
acute disease (1) 1
acute gvhd (1) 1
acute lymphocytic leukemia (1) 1
acute promyelocytic leukemia (1) 1
adenocarcinoma (1) 1
adherence evaluation (1) 1
adolescence (1) 1
adolescents (1) 1
adults (1) 1
afforestation (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 9, pp. 966 - 974
Journal Article
Journal of Environmental Management, ISSN 0301-4797, 12/2017, Volume 203, Issue Pt 1, pp. 51 - 58
Fertilization of plantations using sewage sludge on unfertile tropical soils represents an alternative to using mineral N and P fertilizers. A 44-month field... 
Organic fertilizer | Eucalypt | Biosolid | Planted forest | Unfertile tropical soils | MANAGEMENT | AFFORESTATION | BRAZIL | ENVIRONMENTAL SCIENCES | BIOSOLIDS | GRANDIS | GROWTH | NUTRIENTS | NITROGEN | ABSORPTION | LIGHT USE EFFICIENCY | Soil | Eucalyptus | Sewage | Wood | Fertilizers | Soils | Sludge | Fertilizer industry | Analysis | Plantations | Organic fertilizers
Journal Article
Annals of Hematology, ISSN 0939-5555, 2/2013, Volume 92, Issue 2, pp. 185 - 189
Journal Article
by Dimopoulos, Meletios A and Dimopoulos, Athanasios and Gay, Francesca and Schjesvold, Fredrik and Beksac, Meral and Hajek, Roman and Weisel, Katja Christina and Weisel, Katja and Goldschmidt, Hartmut and Maisnar, Vladimir and Moreau, Philippe and Min, Chang Ki and Pluta, Andrzej and Pluta, Agnieszka and Chng, Wee Joo and Chng, Wee-Joo and Kaiser, Martin and Zweegman, Sonja and Mateos, Maria-Victoria and Mateos, Maria Victoria and Spencer, Andrew and Iida, Shinsuke and Morgan, Gareth and Suryanarayan, Kaveri and Teng, Zhaoyang and Skacel, Tomas and Palumbo, Antonio and Dash, Ajeeta B and Gupta, Neeraj and Labotka, Richard and Rajkumar, S Vincent and Bar, Daniel and Basso, Alfredo and Fantl, Dorotea and He, Simon and Horvath, Neomi and Lee, Cindy and Lee, Jae Hoon and Rowlings, Phillip and Taylor, Kerry and Cochrane, Tara and Kwok, Fiona and Ramanathan, Sundreswran and Agis, Hermine and Zojer, Niklas and Kentos, Alain and Offner, Fritz and Van Droogenbroeck, Jan and Wu, Ka Lung and Maiolino, Angelo and Martinez, Gracia and Zanella, Karla and Capra, Marcelo and Araújo, Sérgio and Gregora, Evzen and Pour, Ludek and Scudla, Vlastimil and Spicka, Ivan and Abildgaard, Niels and Andersen, Niels and Jensen, Bo Amdi and Helleberg, Carsten and Plesner, Torben and Salomo, Morten and Svirskaite, Asta and Delarue, Richard and Blau, Igor and Schieferdecker, Aneta and Teleanu, Veronica and Munder, Markus and Röllig, Christoph and Salwender, Han-Juergen and Fuhrmann, Stephan and Duerig, Jan and Zeis, Matthias and Klein, Stefan and Reimer, Peter and Schmidt, Christian and Scheid, Christof and Mayer, Karin and Hoffmann, Martin and Sosada, Markus and Delimpasi, Sosana and Kyrtsonis, Mary-Christine and Anagnostopoulos, Achilleas and Nagy, Zsolt and Illés, Árpád and Egyed, Miklós and Borbényi, Zita and Mikala, Gabor and Dally, Najib and Horowitz, Netanel and Gutwein, Odit and Nemets, Anatoly and Vaxman, Iuliana and Shvetz, Olga and Trestman, Svetlana and Ruchlemer, Rosa and Nagler, Arnon and Tadmor, Tamar and ... and TOURMALINE-MM3 Study Grp and TOURMALINE-MM3 study group
The Lancet, ISSN 0140-6736, 01/2019, Volume 393, Issue 10168, pp. 253 - 264
Journal Article
by Robak, Tadeusz and Jin, Jie and Pylypenko, Halyna and Verhoef, Gregor and Siritanaratkul, Noppadol and Drach, Johannes and Raderer, Markus and Mayer, Jiri and Pereira, Juliana and Tumyan, Gayane and Okamoto, Rumiko and Nakahara, Susumu and Hu, Peter and Appiani, Carlos and Nemat, Sepideh and Cavalli, Franco and Van Hoof, Achiel and Sheliga, Adriana and Teixeira, Adriana and Tomita, Akihiro and Rocafiguera, Albert Oriol and Suvorov, Alexander and Kuzmin, Alexy and Khojasteh, Ali and Mezlini, Amel and Golenkov, Anatoly and Bosly, Andre and Belch, Andrew and Van De Velde, Ann and Illes, Árpád and Mukhopadhyay, Ashis and Meddeb, Balkis and De Prijck, Bernard and Garichochea, Bernardo and Undar, Bulent and Gabarrón, Caballero and Cao, Carmen and Souza, Carmino and Farber, Charles and Won Suh, Cheol and Burcoveanu, Cristina Ileana and Cebotaru, Cristina Ligia and Truica, Cristina-Ligia and Maruyama, Dai and Belada, David and Ben Yehuda, Dina and Udovitsa, Dmitry and Dolores and Morra, Enrica and Späth-Schwalbe, Ernst and Gonzalez-Barca, Eva and Osmanov, Evgenii and Capote, Francisco Javier and Offner, Fritz and Cardenas, Galvez and Heß, Georg and Manikhas, Georgii and Babu, Govind and Rekhtman, Grigoriy and Rossi, Guiseppe and Marques, Herlander and Marques, Margarida and Bumbea, Horia and Wang, Zhao and Wang, Huaqing and Huang, Huiqiang and Choi, Ilseung and Bulavina, Irina and Lysenko, Irina and Avivi, Irit and Kryachok, Iryna and Zaucha, Jan Maciej and Novak, Jan and Díaz, Joaquín and Demeter, Judit and Alexeeva, Julia and Zhu, Jun and Vilchevskaya, Kateryna and Ishizawa, Kenichi and Mauricio, Kenny and Tobinai, Kensei and Ando, Kiyoshi and Abdulkadryrov, Kudrat and Shih, Lee-Yung and Kuzina, Lyudmila and Gumus, Mahmut and De Wit, Maike and Capra, Marcelo and Golubeva, Marina and Ojeda-Uribe, Mario and Kyselyova, Maryna and Taniwaki, Masafumi and Federico, Massimo and Crump, Michael and Baccarani, Michele and Ogura, Michinori and Egyed, Miklós and Udvardy, Miklos and Kurosawa, Mitsutoshi and Uike, Naokuni and ... and LYM-3002 investigators
The Lancet Oncology, ISSN 1470-2045, 11/2018, Volume 19, Issue 11, pp. 1449 - 1458
In the LYM-3002 study, the efficacy and safety of frontline bortezomib plus rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) and rituximab,... 
NON-INFERIORITY | TRIAL | 1ST-LINE TREATMENT | IMMUNOCHEMOTHERAPY | MULTICENTER | NETWORK | MANAGEMENT | ONCOLOGY | PLUS RITUXIMAB | GUIDELINES | INDOLENT | Anthracyclines | Cyclophosphamide | Corticosteroids | Bortezomib | Analysis | Prednisone | Steroids
Journal Article
by Cadavid, Diego and Mellion, Michelle and Hupperts, Raymond and Edwards, Keith and Edwards, Keith R and Calabresi, Peter A and Drulović, Jelena and Giovannoni, Gavin and Hartung, Hans-Peter and Arnold, Douglas L and Fisher, Elizabeth and Rudick, Richard and Mi, Sha and Chai, Yi and Li, Jie and Zhang, Yiwei and Cheng, Wenting and Xu, Lei and Zhu, Bing and Green, Susan M and Chang, Ih and Deykin, Aaron and Sheikh, Sarah I and Agüera Morales, Eduardo and Al Khedr, Abdullatif and Ampapa, Radek and Arroyo, Rafael and Belkin, Martin and Bonek, Robert and Boyko, Alexey and Capra, Ruggero and Centonze, Diego and Clavelou, Pierre and Debouverie, Marc and Drulovic, Jelena and Evangelou, Nikos and Evdoshenko, Evgeniy and Fernández, Oscar and Fernández Sánchez, Victoria and Freedman, Steven and Freedman, Mark and Fryze, Waldemar and Garcia-Merino, Antonio and Gavric-Kezic, Mira and Ghezzi, Angel and Gout, Olivier and Grimaldi, Luigi and Hendin, Barry and Hertmanowska, Hanka and Hintzen, Rogier and Hradilek, Pavel and Ilkowski, Jan and Ivashinenkova, Evelina and Izquierdo, Guillermo and Jacques, Francois and Jakab, Gabor and Khabirov, Farit and Klodowska-Duda, Gabriela and Komoly, Samuel and Kostic, Smiljana and Kovarova, Ivana and Kremenchuzky, Marcelo and Laganke, Christopher and LaPierre, Yves and Maciejowski, Maciej and Maison, Francois Grand and Marfia, Girolama Alessandra and Martínez Yélamos, Sergio and Meluzinova, Eva and Montalban, Xavier and Murray, Ronald and Naismith, Robert and Newsome, Scott and Nguyen, Viet and Oreja, Delia and Pardo, Gabriel and Pasechnik, Elena and Patti, Francesco and Potemkowski, Andrzej and Prokopenko, Semen and Qian, Peiqing and Rodríguez-Antigüedad, Alfredo and Rossman, Howard and Rozsa, Csilla and Sánchez López, Fernando and Selmaj, Krzysztof and Silber, Eli and Stepien, Adam and Stepniewska, Anna and Swiat, Maciej and Toncev, Gordana and Tourbah, Ayman and Trushnikova, Tatyana and Uccelli, Antonio and Vachova, Marta and Valis, Martin and Vecsei, Laszlo and Wiertlewski, Sandrine and Zaffaroni, Mauro and Zielinski, Tomasz and SYNERGY Study Investigators and SYNERGY study investigators
The Lancet Neurology, ISSN 1474-4422, 09/2019, Volume 18, Issue 9, pp. 845 - 856
Journal Article
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, ISSN 2212-4403, 2016, Volume 123, Issue 2, pp. e57 - e57
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 155 - 155
Abstract Background: Isatuximab (ISA) targets CD38-expressing tumor cells through a combination of activities, including antibody-dependent cellular... 
Journal Article